U.S. surgeon and medical student attitudes toward organ donation.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 19667892)

Published in J Trauma on August 01, 2009

Authors

Mark J Hobeika1, Ronald Simon, Rajesh Malik, H Leon Pachter, Spiros Frangos, Omar Bholat, Sheldon Teperman, Lewis Teperman

Author Affiliations

1: Department of Surgery, New York University School of Medicine, New York, NY 10016, USA.

Articles by these authors

(truncated to the top 100)

Rifaximin treatment in hepatic encephalopathy. N Engl J Med (2010) 9.60

Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet (2007) 5.19

Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol (2004) 3.49

The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl (2002) 3.44

HER-2 amplification is highly homogenous in gastric cancer. Hum Pathol (2009) 3.37

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med (2015) 3.13

Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell (2013) 3.08

Perspective: Malpractice in an academic medical center: a frequently overlooked aspect of professionalism education. Acad Med (2011) 2.68

SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia. J Clin Invest (2011) 2.60

Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res (2004) 2.55

In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J Clin Invest (2009) 2.53

Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg (2008) 2.47

Marked gene transcript level alterations occur early during radical prostatectomy. Eur Urol (2007) 2.41

Prevalence of KIT expression in human tumors. J Clin Oncol (2004) 2.40

Expression and prognostic relevance of annexin A3 in prostate cancer. Eur Urol (2008) 2.32

High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer. Breast Cancer Res Treat (2004) 2.14

The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study. Breast Cancer Res Treat (2005) 2.10

Rhinosinusitis: Establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg (2004) 2.01

Utility of the Military Acute Concussion Evaluation as a screening tool for mild traumatic brain injury in a civilian trauma population. J Trauma Acute Care Surg (2015) 1.98

Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials. Hepatology (2005) 1.97

Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol (2004) 1.95

International experience, electives, and volunteerism in surgical training: a survey of resident interest. J Am Coll Surg (2007) 1.91

Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer. Am J Pathol (2012) 1.80

ERG status is unrelated to PSA recurrence in radically operated prostate cancer in the absence of antihormonal therapy. Clin Cancer Res (2011) 1.75

Influence of slide aging on results of translational research studies using immunohistochemistry. Mod Pathol (2004) 1.75

Stercoral colitis leading to fatal peritonitis: CT findings. AJR Am J Roentgenol (2005) 1.71

Right ventricular outflow versus apical pacing in pacemaker patients with congestive heart failure and atrial fibrillation. J Cardiovasc Electrophysiol (2003) 1.66

AMACR expression in colorectal cancer is associated with left-sided tumor localization. Virchows Arch (2008) 1.61

Molecular cancer phenotype in normal prostate tissue. Eur Urol (2008) 1.58

A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis. Crit Care Med (2013) 1.58

Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagus. Mod Pathol (2006) 1.56

Impaired gastric acidification negatively affects calcium homeostasis and bone mass. Nat Med (2009) 1.52

Clinical significance of p53 alterations in surgically treated prostate cancers. Mod Pathol (2008) 1.51

Role of TP53 mutations in vulvar carcinomas. Int J Gynecol Pathol (2011) 1.47

Tissue microarrays in drug discovery. Nat Rev Drug Discov (2003) 1.42

CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer. Cancer Res (2013) 1.42

Scirrhous changes in dysplastic nodules do not indicate high-grade status. J Gastroenterol Hepatol (2003) 1.41

E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Oncogene (2004) 1.40

Distinct populations of metastases-enabling myeloid cells expand in the liver of mice harboring invasive and preinvasive intra-abdominal tumor. J Leukoc Biol (2009) 1.37

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer. Clin Cancer Res (2007) 1.36

Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest (2004) 1.35

Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer. Clin Cancer Res (2009) 1.31

Predominance of high-grade pathway in breast cancer development of Middle East women. Mod Pathol (2005) 1.30

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer. Prostate (2010) 1.28

Low level HER2 overexpression is associated with rapid tumor cell proliferation and poor prognosis in prostate cancer. Clin Cancer Res (2010) 1.28

Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion. J Thorac Oncol (2011) 1.26

The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clin Cancer Res (2011) 1.26

TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling. BMC Cancer (2011) 1.26

HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer. J Clin Pathol (2006) 1.24

Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder. Clin Cancer Res (2005) 1.23

Two New York City hospitals' surgical response to the September 11, 2001, terrorist attack in New York City. J Trauma (2003) 1.23

Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive ERG fusion-positive prostate cancers. J Pathol (2013) 1.22

Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver. Hepatology (2007) 1.21

Genome-wide DNA methylation events in TMPRSS2-ERG fusion-negative prostate cancers implicate an EZH2-dependent mechanism with miR-26a hypermethylation. Cancer Discov (2012) 1.21

Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions. Mod Pathol (2013) 1.19

Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates. Cancer Res (2006) 1.17

HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies. Int J Oncol (2004) 1.15

Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers. Hum Pathol (2010) 1.14

Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies. Cancer Res (2011) 1.13

Dendritic cells promote pancreatic viability in mice with acute pancreatitis. Gastroenterology (2011) 1.11

RAD51 overexpression is a negative prognostic marker for colorectal adenocarcinoma. Int J Cancer (2012) 1.10

Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer. Virchows Arch (2011) 1.10

Tissue microarrays for comparing molecular features with proliferation activity in breast cancer. Int J Cancer (2006) 1.07

Clinical review: Acid-base abnormalities in the intensive care unit -- part II. Crit Care (2004) 1.07

Physiologic trauma triage criteria in adult trauma patients: are they effective in saving lives by transporting patients to trauma centers? J Am Coll Surg (2005) 1.07

Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma. Cancer Res (2004) 1.06

SPINK1 expression is tightly linked to 6q15- and 5q21-deleted ERG-fusion negative prostate cancers but unrelated to PSA recurrence. Prostate (2013) 1.06

Close association between HER-2 amplification and overexpression in human tumors of non-breast origin. Mod Pathol (2007) 1.04

Clinical practice guideline: endpoints of resuscitation. J Trauma (2004) 1.03

Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers. PLoS One (2013) 1.02

Marked heterogeneity of ERG expression in large primary prostate cancers. Mod Pathol (2012) 1.02

The timing of surgery for cholecystitis: a review of 202 consecutive patients at a large municipal hospital. Am J Surg (2008) 1.01

Loss of reelin expression in breast cancer is epigenetically controlled and associated with poor prognosis. Am J Pathol (2010) 1.01

Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumors. BMC Med Genet (2010) 1.01

Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma. Cancer (2012) 1.00

Dendritic cell depletion exacerbates acetaminophen hepatotoxicity. Hepatology (2011) 1.00

Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients. Clin Cancer Res (2008) 1.00

TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. Am J Pathol (2004) 1.00

Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant (2011) 0.99

In hepatic fibrosis, liver sinusoidal endothelial cells acquire enhanced immunogenicity. J Immunol (2010) 0.98

Bladder cancer-associated protein, a potential prognostic biomarker in human bladder cancer. Mol Cell Proteomics (2009) 0.98

A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl (2011) 0.97

Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung. BMC Cancer (2010) 0.97

High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition. Clin Cancer Res (2013) 0.97

Randomized, double-blind, placebo-controlled phase II study of single-agent oral talactoferrin in patients with locally advanced or metastatic non-small-cell lung cancer that progressed after chemotherapy. J Clin Oncol (2011) 0.97

The professionalism curriculum as a cultural change agent in surgical residency education. Am J Surg (2011) 0.96

Immunological microenvironment in prostate cancer: high mast cell densities are associated with favorable tumor characteristics and good prognosis. Prostate (2009) 0.95

Amplification of 8q21 in breast cancer is independent of MYC and associated with poor patient outcome. Mod Pathol (2010) 0.95

Clinical significance of different types of p53 gene alteration in surgically treated prostate cancer. Int J Cancer (2014) 0.95

Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J Pathol (2002) 0.94

Effect of intra-operative fluid volume on peri-operative outcomes after pancreaticoduodenectomy for pancreatic adenocarcinoma. J Surg Oncol (2011) 0.94

High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol (2003) 0.94

Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea. Antimicrob Agents Chemother (2013) 0.94

MMSET is highly expressed and associated with aggressiveness in neuroblastoma. Cancer Res (2011) 0.93

Proteomic profiling of mammary carcinomas identifies C7orf24, a gamma-glutamyl cyclotransferase, as a potential cancer biomarker. J Proteome Res (2010) 0.93

Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis. Histopathology (2010) 0.92

High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer. Eur J Cancer (2012) 0.92

The stress of residency: recognizing the signs of depression and suicide in you and your fellow residents. Am J Surg (2012) 0.92

Successful treatment of Bouveret syndrome using holmium: YAG laser lithotripsy. Am Surg (2005) 0.92

Role of fatty-acid synthesis in dendritic cell generation and function. J Immunol (2013) 0.92